By Senator Cory Booker of the Democratic Party of New Jersey and Senator Rand Paul of the Republican Party of Kentucky introduced bipartisan law on Wednesday, expanding their right to attempt federal protection against the psychedelic drugs psychedelic and MDMA. Under the bill entitled Right to Trial Clarification Act, the restrictions of the Federal Controlled Substances Act do not apply to Schedule I medicines for which Phase I clinical trials have been completed. The new provisions apply to physicians and patients with life-threatening medical conditions who use Schedule 1 controlled substances under federal jurisdiction law.
“As a doctor, I know how important the right to try is for patients facing life-threatening conditions.” Paul said in a statement About the law from Booker’s office. “Unfortunately, the federal bureaucracy continues to block patients trying to use Schedule I medicines under trial rights. Together with Senator Booker, he led this bipartisan law and did not disturb the government. We are proud to provide doctors with more resources to assist their patients. “
The Trial Rights Act allows patients diagnosed with life-threatening illnesses or conditions for which conventional treatments have not been effective to use certain treatments that have not yet been approved by the U.S. Food and Drug Administration. .. In most cases, the drug is subject to trial rights after the completion of Phase I clinical trials of the drug and before the drug is approved or approved for use by the FDA. Under the provisions of jurisdiction law, the state has the option of permitting or prohibiting the use of jurisdiction under state law.
Senator said two drugs, MDMA and psilocybin, are promising for the treatment of various mental health conditions such as depression, anxiety, and PTSD. The success and safety of the drugs shown in Phase 1 and Phase 2 clinical trials are very promising, and the FDA has classified both substances as “breakthrough therapies” from currently approved therapies. Also shows a significant improvement.
“Recent studies suggest that MDMA and psilocybin may represent significant advances in mental health and psychopharmacology,” Booker said. “Unfortunately, many eligible patients in urgent need of treatment do not currently have access to these promising treatments. The law puts patients first, makes them life-changing and life-saving medicines. Helps to ensure access to. “
Companion major introduced in the house
A bipartisan duo of members of the House of Representatives who support federal cannabis policy has already signed to support Booker and Paul’s bill and will introduce ancillary legislation in the House of Representatives. Oregon Democrat Earl Blumenauer, who has long supported the reform of the country’s cannabis law, and Nancy Mace, the first Republican who submitted a bill to legalize cannabis last year, responded to the change in jurisdiction law. Expressed support.
“Oregon has a long legacy of giving end-of-life patients access to all treatment options to relieve their condition and improve their quality of life. Patients and doctors are those who fight end-of-life disease. It’s worth discussing treatments that include sirocibin, which researchers have found to immediately and continuously relieve pain, anxiety, and depression, “says Blumenauer. “Federal regulations have hampered access to end-of-life care for too long. This law changes it and ensures that all patients have the right to try it. Senator Booker’s Thank you for your leadership. It’s timely and important. “
“Advances in science and technology often come when we think outside the box and try new things,” Mace said. “This law allows patients to choose alternative options such as psilocybin and MDMA when faced with life-threatening conditions. We know that these chemicals can save lives. Today is an important step forward in medical progress. I would like to thank Senator Booker and Senator Paul for their bipartisan work to bring these exciting new options to the mainstream medical world. “
Booker, New York Senate Leader Chuck Schumer, Oregon Democratic Senator Ron Wyden have the right to try the clarification law just one day before submitting the long-awaited bill to legalize cannabis at the federal level Was introduced to the Senate. “I’m happy to see Congress paying attention to psychedelic issues, especially those that affect the veteran community,” said Shane Pennington, a lawyer at law firm Vicente Sederberg. Veterinarians do not need to go to other countries to access treatments whose evidence has been shown to be safe and effective. “
